HER2 alterations in NSCLC include gene mutations (most commonly small insertions or duplications in exon 20) (17), gene amplification (an increase in HER2 copy number) (18), and protein overexpression. The gene discussed is ERBB2; the disease is non-small cell lung carcinoma.